5-177385766-G-T
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 2P and 3B. PM2BP4_ModerateBP6
The NM_003052.5(SLC34A1):c.25G>T(p.Gly9Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000223 in 1,612,910 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_003052.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SLC34A1 | NM_003052.5 | c.25G>T | p.Gly9Trp | missense_variant | 2/13 | ENST00000324417.6 | |
SLC34A1 | NM_001167579.2 | c.25G>T | p.Gly9Trp | missense_variant | 2/9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SLC34A1 | ENST00000324417.6 | c.25G>T | p.Gly9Trp | missense_variant | 2/13 | 1 | NM_003052.5 | P1 | |
SLC34A1 | ENST00000512593.5 | c.25G>T | p.Gly9Trp | missense_variant | 2/9 | 2 | |||
SLC34A1 | ENST00000504577.5 | c.25G>T | p.Gly9Trp | missense_variant | 2/4 | 4 | |||
SLC34A1 | ENST00000507685.5 | n.109G>T | non_coding_transcript_exon_variant | 2/10 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152080Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000487 AC: 12AN: 246316Hom.: 0 AF XY: 0.0000450 AC XY: 6AN XY: 133260
GnomAD4 exome AF: 0.0000123 AC: 18AN: 1460830Hom.: 0 Cov.: 32 AF XY: 0.0000151 AC XY: 11AN XY: 726626
GnomAD4 genome AF: 0.000118 AC: 18AN: 152080Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74280
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 09, 2024 | The c.25G>T (p.G9W) alteration is located in exon 2 (coding exon 1) of the SLC34A1 gene. This alteration results from a G to T substitution at nucleotide position 25, causing the glycine (G) at amino acid position 9 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 08, 2022 | This sequence change replaces glycine, which is neutral and non-polar, with tryptophan, which is neutral and slightly polar, at codon 9 of the SLC34A1 protein (p.Gly9Trp). This variant is present in population databases (rs148669433, gnomAD 0.04%). This variant has not been reported in the literature in individuals affected with SLC34A1-related conditions. ClinVar contains an entry for this variant (Variation ID: 352953). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Hypophosphatemic nephrolithiasis/osteoporosis 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at